Literature DB >> 28333219

Overweight and obese but not normal weight women with PCOS are at increased risk of Type 2 diabetes mellitus-a prospective population-based cohort study.

M M Ollila1, S West1, S Keinänen-Kiukaaniemi2,3, J Jokelainen2,3, J Auvinen2,3, K Puukka4, A Ruokonen4, M-R Järvelin2,5,6, J S Tapanainen1,7, S Franks8, T T Piltonen1, L C Morin-Papunen1.   

Abstract

Entities:  

Year:  2017        PMID： 28333219      PMCID： PMC6790519          DOI： 10.1093/humrep/dex030

Source DB:  PubMed          Journal:  Hum Reprod        ISSN： 0268-1161            Impact factor:   6.918


× No keyword cloud information.
  12 in total

1.  RS1799817 in INSR associates with susceptibility to polycystic ovary syndrome.

Authors:  Maha H Daghestani
Journal:  J Med Biochem       Date:  2020-01-23       Impact factor: 3.402

2.  Clinical study on polycystic ovary syndrome treated with Diane-35 and Pioglitazone.

Authors:  Chunjing Cao; Yuanyuan Qi; Dongmei Fang; Yan Yu
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

3.  Prevalence of type 2 diabetes mellitus compared between lean and overweight/obese patients with polycystic ovarian syndrome: a 5-year follow-up study.

Authors:  Panicha Chantrapanichkul; Suchada Indhavivadhana; Thanyarat Wongwananuruk; Kitirat Techatraisak; Chongdee Dangrat; Nutchaya Sa-Nga-Areekul
Journal:  Arch Gynecol Obstet       Date:  2020-01-11       Impact factor: 2.493

Review 4.  Sex hormones, obesity and type 2 diabetes: is there a link?

Authors:  Alessandra Gambineri; Carla Pelusi
Journal:  Endocr Connect       Date:  2019-01-01       Impact factor: 3.335

5.  Early pregnancy metabolic factors associated with gestational diabetes mellitus in normal-weight women with polycystic ovary syndrome: a two-phase cohort study.

Authors:  Wei Zheng; Wenyu Huang; Li Zhang; Zhihong Tian; Qi Yan; Teng Wang; Lirui Zhang; Guanghui Li
Journal:  Diabetol Metab Syndr       Date:  2019-08-23       Impact factor: 3.320

6.  An impaired glucagon-like peptide-1 response is associated with prediabetes in polycystic ovary syndrome with obesity.

Authors:  Simona Ferjan; Mojca Jensterle; Tjasa Oblak; Irena Prodan Zitnik; Janja Marc; Katja Goricar; Vita Dolzan; Andrej Janez
Journal:  J Int Med Res       Date:  2019-08-23       Impact factor: 1.671

7.  The cardiovascular risk profile of middle-aged women with polycystic ovary syndrome.

Authors:  Cindy Meun; Marlise N Gunning; Yvonne V Louwers; Henrike Peters; Jolien Roos-Hesselink; Jeanine Roeters van Lennep; Oscar-Leonel Rueda Ochoa; Yolande Appelman; Nils Lambalk; Eric Boersma; Maryam Kavousi; Bart Cjm Fauser; Joop Se Laven
Journal:  Clin Endocrinol (Oxf)       Date:  2019-11-24       Impact factor: 3.478

8.  Metabolic profile of women with PCOS in Brazil: a systematic review and meta-analysis.

Authors:  Ramon Bossardi Ramos; Lucas Bandeira Marchesan; Poli Mara Spritzer; Monica de Oliveira; Enrico Carmina
Journal:  Diabetol Metab Syndr       Date:  2021-02-16       Impact factor: 3.320

9.  Metabolic Features of Women With Polycystic Ovary Syndrome in Latin America: A Systematic Review.

Authors:  Lucas Bandeira Marchesan; Ramon Bossardi Ramos; Poli Mara Spritzer
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-19       Impact factor: 5.555

10.  Serum Trace Elements in Patients With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Jiechen Yin; Xiang Hong; Jun Ma; Yuanqing Bu; Ran Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-17       Impact factor: 5.555
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.